887700葡京线路检测主页

最新葡京线路检测-887700葡京线路检测主页

887700葡京线路检测主页
887700葡京线路检测主页

Overview

gs-1.jpg

  

Fujian Genohope Biotech Ltd. was established in January 2019. It was jointly invested by New Hope Medical Fund and Genovior Biotech Corporation. The planned total investment is about 1 billion yuan. The company is located in Wushi Industrial Park, Putian, Fujian, adjacent to Fuxia Railway and Putian Station on the high-speed highway, with superior geographical location and convenient transportation.

The company occupies a total area of 55 acres and has built an advanced factory area that meets the PIC/S GMP international standards. It focuses on the development and production of high-price peptide drugs, anti-cancer drugs, and biological drugs, as well as all corresponding injections. A high-tech enterprise of CDMO.

The GHB team brings together outstanding talents in biotechnology and medicine related industries at home and abroad. It can not only provide complete design and development, process verification, and quality standard research and formulation of candidate drugs, and provide customers with new formulation development for clinical trials or commercial sales, but also It can provide registration application materials services such as chemistry, manufacturing and control for customer products. The company is one of the few one-stop injection drug commissioned developers in Asia that has the capabilities of CRO, CDO and CMO, and is also one of the few teams with actual mass production experience.

        The production base of GHB can provide commercial dosage forms such as injections, freeze-dried products, pre-filled syringes and cartridges. The company actively promotes the development of globalization and will provide global customers with one-stop biomedicine R&D and production. Integration services. Our one-stop service provides customers with convenient, practical and effective finished pharmaceutical solutions; at the same time, we are also committed to demanding high standards of product quality to ensure the safety of people who use drugs, and hope to become Asia's leading one-stop injection drug contract Development manufacturer.